Skip to main content
PlainMeds

Prescription medicine

Magnesium chloride, potassium chloride and 5 other ingredients Brand names: Isolyte; first approved as Isolyte S Ph

Magnesium chloride, potassium chloride and 5 other ingredients (Isolyte) is a prescription medicine with an FDA approval on record since 1984. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the magnesium chloride, potassium chloride and 5 other ingredients FDA label on DailyMed (effective October 6, 2023, B. Braun Medical Inc.); the NDA 19006 record on Drugs@FDA; every magnesium chloride, potassium chloride and 5 other ingredients label on DailyMed.

Highlights of the record

FDA label of October 6, 2023; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

This solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent.

Forms and strengths

  • 0.53 g/100ml / 0.5 g/100ml / 0.37 g/100ml / 0.037 g/100ml / 0.03 g/100ml / 0.012 g/100ml / 0.00082 g/100ml

Injection (solution).

On the market

Earliest approval on file
April 2, 1984 Isolyte S Ph 7.4 In Plastic Container, B Braun; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
17 through July 30, 2026

What is magnesium chloride, potassium chloride and 5 other ingredients used for?

From the label: indications and usage

This solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent.

FDA pharmacologic class: Calculi Dissolution Agent, Osmotic Laxative and Potassium Salt.

Source: FDA drug label (Isolyte S pH 7.4), B. Braun Medical Inc., effective October 6, 2023 (SPL set 150437b6-320e-4c69-a434-2a26a1f0b2e4), via openFDA; the full label on DailyMed

Is there a generic for magnesium chloride, potassium chloride and 5 other ingredients (Isolyte)?

No generic magnesium chloride, potassium chloride and 5 other ingredients is approved (Drugs@FDA, October 8, 2026).

  • 1984 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the magnesium chloride, potassium chloride and 5 other ingredients label say about other medicines?

The magnesium chloride, potassium chloride and 5 other ingredients label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Corticotropindrug interactionsDrug Interactions Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients.

Check magnesium chloride, potassium chloride and 5 other ingredients against other medicines

Source: FDA drug label (Isolyte S pH 7.4), B. Braun Medical Inc., effective October 6, 2023 (SPL set 150437b6-320e-4c69-a434-2a26a1f0b2e4), via openFDA; the full label on DailyMed

What do FAERS reports show for magnesium chloride, potassium chloride and 5 other ingredients?

The FDA Adverse Event Reporting System holds 17 reports that list magnesium chloride, potassium chloride and 5 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Atrial Fibrillation9
  • Bradycardia8
  • Caesarean Section1
  • Exposure During Pregnancy (a use or a product term, not a reaction)1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other calculi dissolution agents
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other